Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow-to-Debt Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥21.03 Million could theoretically repay 0% of its total liabilities (CN¥82.76 Million) in one year. See Shanghai Yizhong Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see Shanghai Yizhong Pharmaceutical Co Ltd (688091) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Shanghai Yizhong Pharmaceutical Co Ltd. Check Shanghai Yizhong Pharmaceutical Co Ltd (688091) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥39.44 Million | CN¥42.97 Million | ▲ +15.1% |
| 2023 | 0.80x | CN¥86.55 Million | CN¥108.52 Million | ▼ -74.5% |
| 2022 | 3.13x | CN¥110.78 Million | CN¥35.42 Million | ▲ +260.4% |
| 2021 | -1.95x | CN¥-48.78 Million | CN¥25.02 Million | ▼ -47.6% |
| 2020 | -1.32x | CN¥-20.21 Million | CN¥15.30 Million | ▲ +32.3% |
| 2019 | -1.95x | CN¥-23.91 Million | CN¥12.26 Million | ▼ -212.9% |
| 2018 | -0.62x | CN¥-10.68 Million | CN¥17.15 Million | ▲ +12.5% |
| 2017 | -0.71x | CN¥-11.51 Million | CN¥16.17 Million | — |